Caris Life Sciences Inc (MEX:CAI)
MXN 317 (0%) Market Cap: 76.86 Bil Enterprise Value: 69.98 Bil PE Ratio: 0 PB Ratio: 7.40 GF Score: 11/100

Caris Life Sciences Inc at Goldman Sachs Healthcare Conference Transcript

Jun 8, 2026 / 02:40 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CAI.OQ - Caris Life Sciences Inc
Caris Life Sciences Inc at Goldman Sachs Healthcare Conference
Jun 08, 2026 / 02:40PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good. Okay. Great. Hi, everyone. I'm Evie Koslowski, the Life Science Tools and Diagnostics Analyst here at Goldman Sachs. I'm here today with Karis Life Sciences. They're going to start with a presentation, and then we'll open it up to Q&A at the end.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Okay, Evie, thank you.

I'm Brian Brilli. I'm Vice Chairman of Karis Life Sciences. I'm here with Milan Radovich, our CSO, and Luke Power, our CFO.

And I think I would just start by saying that while we've been at this since 2008 when our
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot